Ionis Pharmaceuticals IONS Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's common stock, par value (in dollars per share)?
- Ionis Pharmaceuticals (IONS) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Ionis Pharmaceuticals's common stock, par value (in dollars per share) changed year-over-year?
- Ionis Pharmaceuticals's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Ionis Pharmaceuticals's common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.